At present, key players like Vanda Pharmaceuticals (tradipitant), CinDome Pharma (deudomperidone), Neurogastrx (metopimazine), and Processa Pharmaceuticals (PCS12852) are investigating their candidates for the treatment of gastroparesis and management of its symptoms in the 7MM; these…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.